Orally bioavailable caffeic acid related anticancer drugs
US8779151B2 · kind B2 · utility
1Cited by
15References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 2, 2007 |
| Grant date | Jul 15, 2014 |
| Priority date | — |
| Expiry date | Jul 27, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention concerns compounds and their use to treat cell proliferative diseases such as cancer. Compounds of the present invention display significant potency as inhibitors of Jak2/STAT3 pathways and downstream targets and inhibit the growth and survival of cancerous cell lines.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.